Epidermal growth factor receptor (EGFR) mutations play an important role in the pathogenesis of non-small-cell lung cancer (NSCLC) and are one of the main oncogenic drivers of NSCLC. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.